TEVA
Teva Pharma Industries Ltd
36.50$
-0.6%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.3% | -1.6% | -3.4% | +1.0% | -5.8% | -2.3% | +4.5% | -0.7% | +2.2% | -1.7% | -0.5% | |
| – | +9.3% | -1.5% | -5.4% | +5.9% | +1.9% | -8.2% | +9.5% | +0.9% | +9.5% | -1.7% | +0.4% | |
| – | +43.4% | -7.3% | -24.5% | +47.0% | -0.6% | -48.6% | +27.3% | +1.9% | +61.4% | +5.2% | -2.3% | |
| – | +43.4% | -7.3% | -24.5% | +47.0% | -0.6% | -48.6% | +27.3% | +1.9% | +61.4% | +5.2% | -2.3% | |
| – | +0.7% | +1.4% | +9.0% | -8.1% | -11.6% | +10.6% | +5.3% | +6.9% | -2.7% | -8.5% | +2.9% | |
| – | -0.7% | -1.8% | -0.6% | +0.8% | -24.0% | +8.0% | +7.7% | -5.0% | -4.3% | -0.1% | +1.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.7% | -1.0% | -3.1% | -2.2% | -6.1% | +2.2% | +3.0% | 0.0% | +0.3% | -1.1% | +0.1% | |
| – | -2.5% | -6.1% | -4.0% | -2.0% | -7.1% | -5.2% | -1.1% | -5.0% | -3.9% | -4.5% | -4.5% | |
| – | +2.2% | -0.3% | -1.3% | +1.7% | -5.0% | -4.3% | +3.6% | -2.1% | +0.7% | -3.1% | +0.9% | |
| – | +7.5% | +12.6% | -5.5% | +5.8% | -7.3% | -12.8% | +6.3% | -3.1% | +17.1% | +0.6% | +15.6% | |
| – | +13.0% | +83.0% | -31.6% | +23.2% | -31.0% | -76.4% | +10.2% | -94.8% | +7,483.3% | +43.5% | +72.3% | |
| – | +14.1% | -6.3% | -3.0% | +0.2% | -7.1% | +3.9% | +9.1% | -5.7% | +7.5% | +2.6% | +4.8% | |
| – | -1.8% | -8.7% | -0.2% | -0.9% | -2.4% | +1.4% | +3.3% | +0.0% | -10.6% | -6.5% | -13.7% | |
| – | +8.3% | -3.0% | -12.6% | -4.6% | -11.4% | +16.5% | +9.0% | +6.2% | +9.1% | +4.0% | -5.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | -1.2% | +0.9% | +0.0% | +0.0% | +2.3% | +0.2% | +0.3% | +0.8% | +0.5% | +0.2% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.